Cite
HARVARD Citation
Sartor, O. et al. (2019). Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases. Prostate. 79 (14), pp. 1683-1691. [Online].